Skip to main content
SpringerLink
Log in

Gabapentin Extended-Release — Depomed

Gabapentin ER, Gabapentin Gastric Retention, Gapapentin GR

  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

References

  1. Depomed Inc. Depomed Acquires Exclusive Rights to Gabapentin GR. Media Release: 22 Sep 2003. Available from URL: http://www.depomedinc.com

    Google Scholar 

  2. Depomed Inc. Depomed and Elan Enter into Termination Agreement. Media Release: 22 Sep 2003. Available from URL: http://www.depomedinc.com

    Google Scholar 

  3. Depomed Inc. Depomed Acquires Remaining Interest in Majority-Owned Subsidiary. Media Release: 7 Jun 2004. Available from URL: http://www.depomedinc.com

    Google Scholar 

  4. Depomed Inc. Depomed Obtains Exclusive License to Gabapentin Use in Hot Flashes. Media Release: 18 Oct 2006. Available from URL: http://www.depomedinc.com

    Google Scholar 

  5. Depomed Inc. Depomed Reports Dose Proportionality of Gabapentin GR at the Endocrine Society’s Annual Meeting. Media Release: 26 Jun 2006. Available from URL: http://www.depomedinc.com

  6. Depomed Inc. Depomed Completes Enrollment for Phase II Clinical Trial for Gabapentin GR(TM). Media Release: 24 Oct 2005. Available from URL: http://www.depomedinc.com

  7. Depomed Inc. Depomed Reports Second Quarter 2006 Financial Results; Revenues Increase to $2.2 Million Compared to $428,000 in 2005. Media Release: 7 Aug 2006. Available from URL: http://www.depomedinc.com

    Google Scholar 

  8. Depomed Inc. Depomed Expands Patent Portfolio for Drug Delivery Technology. Media Release: 11 May 2004. Available from URL: http://www.depomedinc.com

    Google Scholar 

  9. Depomed Inc. Depomed Announces Results of Phase 3 Clinical Trial for Gabapentin GR™ In Postherpetic Neuralgia. Media Release: 10 Jul 2007. Available from URL: http://www.de-pomedinc.com

    Google Scholar 

  10. Depomed Inc. Depomed Announces Positive Results of Phase II Clinical Trial for Gabapentin GR(TM) in Postherpetic Neural Media Release: 4 Jan 2006. Available from URL: http://www.depomedinc.com

    Google Scholar 

  11. Depomed Inc. Depomed Announces Strong Positive Phase II Trial Results for Once Daily Gabapentin GR™ to Treat Symptoms of Diabetic Peripheral Neuropathy. Media Release: 13 Dec 2006. Available from URL: http://www.depomedinc.com

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gabapentin Extended-Release — Depomed. Drugs R D 8, 317–320 (2007). https://doi.org/10.2165/00126839-200708050-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-200708050-00005

Keywords

Search

Navigation